News | August 12, 2023
IPCA Laboratories posts Q1 FY24 consolidated PAT at Rs. 162.82 Cr
IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023
IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023
The company will submit its comprehensive response on these observations to the USFDA
The company will submit its comprehensive response on these observations to the US FDA
The company has extended its full co-operation and support to the officials of the Income Tax Department
The company will submit its comprehensive response on these observations to the US FDA within the stipulated time
The company has reported total income of Rs. 1607.85 crores during the period ended June 30, 2022.
The company has posted net profit of Rs.884.08 crores for the Financial Year ended March 31, 2022.
For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore
With the acquisition of these further shares, TWPL has now become company's subsidiary.
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)